References
- Feldman A R, Kesslers L, Myers M H, et al. The prevalence of cancer. N Engl J Med 1986; 315: 1394–1397
- Markman M. The ethical dilemma of clinical trials of new chemotherapeutic agents in cancer patients. CA-A Ca J Clin 1986; 36: 367–369
- Eddy D M. Appropriateness of cervical cancer screening. Gynecol Oncol 1981; 12: S168–S187
- Gossel E T, Carr J M, McDonagh J. Detection of malignant tumors: Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 1986; 315: 1369–1376
- Rees G KG. Cost-effectiveness in oncology. Lancet 1985; 2: 1405–1408
- Rosenberg S A, Lotze M T, Muul L M, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889–897